Detalhe da pesquisa
1.
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.
Mult Scler
; 30(1): 63-70, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38131621
2.
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Ann Neurol
; 91(1): 89-100, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687063
3.
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Mult Scler
; 29(8): 979-989, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37431627
4.
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK.
BMJ Open
; 13(5): e071656, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37197821
5.
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Mult Scler Relat Disord
; 63: 103894, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636271
6.
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.
Mult Scler Relat Disord
; 64: 103937, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700625